Carbamazepine Prescribing Information to Include Recommendation of Genetic Test for Patients with Asian Ancestry

The FDA announced yesterday that the Carbamazepine drug label will now recommend HLA-B* 1502 genetic testing of patients with Asian ancestry prior to initiation of therapy. About 6 in 1000 Asian patients have a variation of this immune system gene that increases the risk for developing Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), or drug [...]

An Interesting Drug-Drug Interaction

A case and comment are reported in Currents in Affective Medicine Nov 2007 which reflect an interesting drug-drug interaction.  A child with OCD was well treated with clomipramine 150mg/day. A diagnosis of bipolar disorder while he was in the hospital was treated with oxcarbazepine 600mg bid.  The treater states that the child’s sleep improved as [...]

Worshiping at the Altar of Randomized Trials

AHRQ’s Evidence Report on Depression, CYP450 Testing for Adults Treated with SSRIs concluded “There is a paucity of good-quality data addressing the questions of whether testing for CYP450 polymorphisms in adults entering SSRI treatment for non-psychotic depression leads to improvement in outcomes, or whether testing results are useful in medical, personal, or public health decisionmaking.” [...]

Cytochrome P450 testing for better psychiatric care

J Psychosoc Nurs Ment Health Serv. 2007 Oct;45(10):15-8. Link: Cytochrome P450 testing for better psychiatric care. Pestka EL, Hale AM, Johnson BL, Lee JL, Poppe KA. Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN 55905, USA. pestka.elizabeth@mayo.edu Genotyping for CYP2D6 and CYP2C19 variations is emerging as a potentially useful clinical tool to help mental [...]

Follow

Get every new post delivered to your Inbox.